Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multiloculalis

被引:25
作者
Mathis, A
Wild, P
Boettger, EC
Kapel, CMO
Deplazes, P
机构
[1] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland
[2] Univ Zurich, Electron Microscopy Unit, CH-8057 Zurich, Switzerland
[3] Univ Zurich, Inst Vet Anat, CH-8057 Zurich, Switzerland
[4] Univ Zurich, Inst Virol, CH-8057 Zurich, Switzerland
[5] Univ Zurich, Inst Med Mikrobiol, CH-8006 Zurich, Switzerland
[6] Royal Vet & Agr Univ, Danish Ctr Expt Parasitol, DK-1870 Frederiksberg, Denmark
关键词
D O I
10.1128/AAC.49.8.3251-3255.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The mitochondrial rRNA of the tapeworm species Echinococcus multilocularis carries an adenine at sequence position 2058 (numbering according to that for Escherichia coli) of the large-subunit rRNA (IsrRNA), while the nucleus-encoded rRNA, as determined in this study, is characterized by 2058G. This indicates a dichotomy in the drug susceptibilities of ribosomes: cytoplasmic ribosomes are predicted to be resistant to macrolide antibiotics, while mitochondrial ribosomes lack the most common chromosomal resistance determinant, IsrRNA 2058G. Upon incubation with the macrolide clarithromycin, the formation of vesicles from metacestode tissue was reduced in a dose-dependent manner. Electron microscopy revealed distinct morphological alterations both of the mitochondria and of the vesicle wall (e.g., loss of microtriches) in drug-treated vesicles. Adult worms lost their motility and displayed morphological changes (shortening and constriction of proglottids and the presence of vacuoles) upon incubation with clarithromycin. Our findings demonstrate that macrolides have distinct in vitro effects on E. multilocularis, endorsing the use of sequence-based in silico approaches for exploitation of available ribosomal drugs as anthelmintic agents.
引用
收藏
页码:3251 / 3255
页数:5
相关论文
共 36 条
  • [1] Cestodes - Echinococcus
    Ammann, RW
    Eckert, J
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1996, 25 (03) : 655 - +
  • [2] [Anonymous], 2001, WHO OIE MANUAL ECHIN
  • [3] AZITHROMYCIN, A MACROLIDE ANTIBIOTIC WITH POTENT ACTIVITY AGAINST TOXOPLASMA-GONDII
    ARAUJO, FG
    GUPTILL, DR
    REMINGTON, JS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) : 755 - 757
  • [4] INHIBITION OF CYTOPLASMIC AND ORGANELLAR PROTEIN-SYNTHESIS IN TOXOPLASMA-GONDII - IMPLICATIONS FOR THE TARGET OF MACROLIDE ANTIBIOTICS
    BECKERS, CJM
    ROOS, DS
    DONALD, RGK
    LUFT, BJ
    SCHWAB, JC
    CAO, Y
    JOINER, KA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) : 367 - 376
  • [6] Structural basis for selectivity and toxicity of ribosomal antibiotics
    Böttger, EC
    Springer, B
    Prammananan, T
    Kidan, Y
    Sander, P
    [J]. EMBO REPORTS, 2001, 2 (04) : 318 - 323
  • [7] An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii
    Camps, M
    Arrizabalaga, G
    Boothroyd, J
    [J]. MOLECULAR MICROBIOLOGY, 2002, 43 (05) : 1309 - 1318
  • [8] Thiostrepton binds to malarial plastid rRNA
    Clough, B
    Strath, M
    Preiser, P
    Denny, P
    Wilson, I
    [J]. FEBS LETTERS, 1997, 406 (1-2) : 123 - 125
  • [9] Derouin F, 2001, Curr Opin Investig Drugs, V2, P1368
  • [10] Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern
    Eckert, J
    Deplazes, P
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (01) : 107 - +